Mirna Therapeutics Secures $1,500,000 New Financing

  • Feed Type
  • Date
    8/23/2011
  • Company Name
    Mirna Therapeutics
  • Mailing Address
    2150 Woodward St. Austin, TX 78744
  • Company Description
    Mirna Therapeutics, Inc., traces its lineage back to Ambion, Inc., a privately held company that offered research reagents for RNA analysis. It was at Ambion where Mirna’s miRNA therapeutic research and development program began in 2002 when the first molecular biology tools were developed for studying miRNAs. Ambion scientists started using these tools themselves to compare the miRNA expression patterns of tumor and normal adjacent tissue.
  • Website
    http://www.mirnatherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds of this financing combined with our significant state funding will continue to support our developmentefforts as we complete our preclinical work towards submitting an IND by the end of 2012.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy